Covid-19 Medicine Released – New Date For IPL 2020
Hello all of us nowadays a historic day for us that India released 1st Covid-19 medicine released
So there is a chance of new Date For IPL 2020 .
Everyone knows that due to Covid-19 IPL 2020 has canceled for this year 20020.
Covid-19 Cases In India :
Nowadays Covid-19 patients gradually increase in India and now India is the 4 topmost country in the World in Corona case.
The death rate also increases rapidly.
To avoid the spread of coronavirus and to maintain the social distance BCCI postponed the IPL for the year 2020.
Relesed Medicine For Prevntion Of Coronaa Virus :
There is good news in it that Covid-19 Medicine Released which can slow down the Covid-19 patients.
Glenmark has received a green signal to manufacture and marketing the medicine in India to moderate the rapid increase of coronavirus cases.
After getting approval from Drugs Controller General Of India(DCGI),
Glenmark pharmaceuticals have lunched the medicine FabFlui for the treatment of coronavirus patient.
According to the prescription of pharmacy, the strip of 200 mg has a total no of 34 tablets and at a cost of RS103 per tablet.
A new positive patient takes 800mg twice a day and it will continue for the next 14 days.
The drug Remdesivir has been grant approval by DCGI for the treatment of a suspect.
Also, laboratory-confirmed cases of Covid-19 in adults and youngsters, hospitalized with severe symptoms.
COVIFOR is going to be available in 100 mg vials (injectable) which must be administered intravenously during a hospital facility
Under the right supervision of a doctor or trained healthcare worker.
The company preparing to make sure the supply of enough stocks required to cater to this need.
We’ll still work closely with the govt and medical profession to form a difference within the fight against Covid-19.
This product indigenously in line with Prime Minister Narendra Modi’s Make in India campaign but it takes time.
The medicine is going to be launched within the country under a contract with Gilead Sciences Inc.
Therefore It can expand access to affordable Covid-19 treatment in low and middle-income countries.
Upcoming Series in 2020 – See Here
More Info At Official Link – Click Here